Quoin Pharmaceuticals, Ltd. (QNRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 15.33M | 20.01M | 6.02M | 8.48M | 12.5M | 14.93M | 10.5M | 13.22M | 15.26M | 11.29M | 14.14M | 15.67M |
| Cash & Short-Term Investments | 3.12M | 3.82B | 5.41M | 7.79M | 11.55M | 14.06M | 10.31M | 12.57M | 14.69M | 10.69M | 13.98M | 15.44M |
| Cash Only | 3.12M | 3.82B | 1.83M | 1.67M | 3.82M | 3.62M | 3.12M | 2.85M | 1.83M | 2.4M | 3.16M | 4.76M |
| Short-Term Investments | 0 | 14.93M | 3.58M | 6.12M | 7.73M | 10.43M | 7.19M | 9.73M | 12.86M | 8.29M | 10.82M | 10.68M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 12.21M | -3.8B | 0 | 0 | 0 | 0 | 190.54K | 650.7K | 574.9K | 32.58K | 0 | 0 |
| Total Non-Current Assets | 358.33K | 383.33K | 408.33K | 433.33K | 458.33K | 783.33K | 891.72K | 833.33K | 858.33K | 883.33K | 926.53K | 1.04M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 358.33K | 383.33M | 408.33K | 433.33K | 458.33K | 483.33K | 508.33K | 533.33K | 558.33K | 583.33K | 626.53K | 652.54K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | -382.95M | 0 | 0 | 0 | 300K | 383.39K | 300K | 300K | 300K | 300K | 383.39K |
| Total Assets | 15.69M | 20.39M | 6.42M | 8.91M | 12.96M | 15.71M | 11.39M | 14.05M | 16.12M | 12.17M | 15.07M | 16.71M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 21.13% | 29.8% | -43.6% | -36.59% | -19.65% | 29.09% | -24.41% | -15.89% | -12.61% | -15.83% | -8.34% | 286.68% |
| Total Current Liabilities | 5.35M | 5.55M | 5.76M | 4.34M | 4.86M | 4.18M | 3.47M | 3.95M | 4.22M | 3.58M | 4.58M | 4.41M |
| Accounts Payable | 1.78M | 1.26M | 1.86M | 873.68K | 644.06K | 905.7K | 222.64K | 819.67K | 358.51K | 526.52K | 239.98K | 707.93K |
| Days Payables Outstanding | 5.48K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.57M | 4.28M | 416.94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 2.87x | 3.61x | 1.04x | 1.95x | 2.57x | 3.57x | 3.02x | 3.35x | 3.61x | 3.15x | 3.09x | 3.55x |
| Quick Ratio | 2.87x | 3.61x | 1.04x | 1.95x | 2.57x | 3.57x | 3.02x | 3.35x | 3.61x | 3.15x | 3.09x | 3.55x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.57M | 1.72M | 1.87M | 2.02M | 2.17M | 2.32M | 2.47M | 2.62M | 2.77M | 2.92M | 3.07M | 3.22M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.57M | 1.72M | 1.87M | 2.02M | 2.17M | 2.32M | 2.47M | 2.62M | 2.77M | 2.92M | 3.07M | 3.22M |
| Total Liabilities | 6.92M | 7.27M | 7.64M | 6.36M | 7.03M | 6.5M | 5.95M | 6.58M | 7M | 6.51M | 7.65M | 7.64M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -3.12M | -3.82B | -1.83M | -1.67M | -3.82M | -3.62M | -3.12M | -2.85M | -1.83M | -2.4M | -3.16M | -4.76M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 8.77M | 13.12M | -1.21M | 2.55M | 5.93M | 9.2M | 5.44M | 7.48M | 9.13M | 5.66M | 7.41M | 9.07M |
| Equity Growth % | 48.05% | 42.54% | -122.32% | -65.88% | -35.06% | 62.51% | -26.6% | -17.57% | -16.39% | -23.53% | -19.13% | 386.35% |
| Book Value per Share | 4.47 | 8.76 | -2.07 | 4.34 | 10.11 | 49.35 | 1.09 | 1.48 | 4.34 | 5.74 | 7.51 | 9.19 |
| Total Shareholders' Equity | 8.77M | 13.12M | -1.21M | 2.55M | 5.93M | 9.2M | 5.44M | 7.48M | 9.13M | 5.66M | 7.41M | 9.07M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -75.97M | -70.97M | -66.62M | -62.67M | -58.98M | -55.17M | -52.85M | -50.5M | -48.53M | -46.2M | -44.15M | -42.23M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.93M | -2.93M |
| Accumulated OCI | -159 | -612 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |